India Pharmaceuticals and Healthcare Report Q4 2013:Life Sciences Market Research Reports

Life Sciences Market Research Reports

Kinvey Strategy eBook Kinvey answers 7 critical questions about creating your mobile strategy and technology policies. See our answers in this free eBook. From our sponsors

India Pharmaceuticals and Healthcare Report Q4 2013 Oct 16th 2013, 00:00, by swapnil BMI View: Pharmaceutical firms continue to post varying results in India due to the government’s introduction of policies targeting the pharmaceutical industry. These include patent disrespect and pricecontainment policies for both generic and patented drugs. We maintain our bearish view on the sector and highlight that domestic firms with a large exposure to overseas markets will continue to fare well. Headline Expenditure Projections Pharmaceuticals: INR840.0bn (US$15.7bn) in 2012 to INR921.2bn (US$16.5bn) in 2013; +9.7% in local currency terms and +4.6% in US dollar terms. Forecast broadly in line with Q313, although growth in US dollar terms was impacted by the … Order / Buy a copy of this report @ http://www.rnrmarketresearch.com/contacts/purchase?rname=120574. Complete report details with Table of Contents and more @ http://www.rnrmarketresearch.com/india-pharmaceuticals-and-healthcare-report-q4-2013-market-report.html.

You are receiving this email because you subscribed to this feed at blogtrottr.com. If you no longer wish to receive these emails, you can unsubscribe from this feed, or manage all your subscriptions